• • Includes new drug interaction tables, drug risk profiles, and FDA guidelines, as well as two new appendices that summarize chapter questions and summarize highest-risk drug interactions.

• • Covers the best uses for new biologic therapeutics.

• • Contains new chapters covering medical decision-making principles, PDE-4 and JAK inhibitors, interleukin 17 inhibitors, interleukin 23 inhibitors, additional biologic therapeutics, and hedgehog pathway inhibitors.

• • Contains quick-access summaries of indications/contraindications, dosage guidelines, drug interactions, drug monitoring guidelines, adverse effects, and treatment protocols.

• • Features a highly detailed, disease-specific index, as well as purchase information for major drugs.

• Helps you assess your knowledge and prepare for certification or recertification with about 800 review questions and answers throughout the book.
• Enhanced eBook version included with purchase. Your enhanced eBook allows you to access all of the text, figures, and references from the book on a variety of devices.

search tags: stefen e wolverton, stephen e wolverton, sttefen e volverton, steffen e wollvarton